Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 9, 2013 - Issue 4
Submit an article Journal homepage
1,457
Views
16
CrossRef citations to date
0
Altmetric
Meeting Report

Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies

Jagadeesh Bayry Institut National de la Santé et de la Recherche Médicale, Unité 872, Centre de Recherche des Cordeliers, 15 rue de l’Ecole de Médecine, 75006 Paris, France. [email protected]; Institut National de la Santé et de la Recherche Médicale, Unité 872, Centre de Recherche des Cordeliers, 15 rue de l’Ecole de Médecine, 75006 Paris, France. [email protected]
&
Timothy R Radstake University Medical Center Utrecht, Department of Rheumatology & Clinical Immunology, Laboratory of Translational Immunology, Heidelberglaan 100, 3584CX Utrecht, The Netherlands; University Medical Center Utrecht, Department of Rheumatology & Clinical Immunology, Laboratory of Translational Immunology, Heidelberglaan 100, 3584CX Utrecht, The Netherlands
Pages 297-299 | Published online: 10 Jan 2014

References

  • Youinou P, Pers JO, Gershwin ME, Shoenfeld Y. Geo-epidemiology and autoimmunity. J. Autoimmun. 34(3), J163–J167 (2010).
  • Alzabin S, Venables PJ. Etiology of autoimmune disease: past, present and future. Expert Rev. Clin. Immunol. 8(2), 111–113 (2012).
  • Broen JC, Coenen MJ, Radstake TR. Deciphering the genetic background of systemic sclerosis. Expert Rev. Clin. Immunol. 7(4), 449–462 (2011).
  • Diaz-Gallo LM, Martin J. Common genes in autoimmune diseases: a link between immune-mediated diseases. Expert Rev. Clin. Immunol. 8(2), 107–109 (2012).
  • Jungel A, Distler JH, Gay S, Distler O. Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev. Clin. Immunol. 7(4), 475–480 (2011).
  • Maddur MS, Vani J, Lacroix-Desmazes S, Kaveri S, Bayry J. Autoimmunity as a predisposition for infectious diseases. PLoS Pathog. 6(11), e1001077 (2010).
  • Ibrahim I, Owen SA, Barton A. Genetics and the impact on treatment protocols in patients with rheumatoid arthritis. Expert Rev. Clin. Immunol. 8(6), 509–511 (2012).
  • Raza A, Yousaf W, Giannella R, Shata MT. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev. Clin. Immunol. 8(2), 161–168 (2012).
  • Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am. J. Pathol. 181(1), 8–18 (2012).
  • Lehmann B, Schwab I, Bohm S, Lux A, Biburger M, Nimmerjahn F. Fc RIIB: a modulator of cell activation and humoral tolerance. Expert Rev. Clin. Immunol. 8(3), 243–254 (2012).
  • Herlin T. Tocilizumab for the treatment of systemic juvenile idiopathic arthritis. Expert Rev. Clin. Immunol. 8(6), 517–525 (2012).
  • Bayry J. Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases. Immunotherapy 4(1), 9–12 (2012).
  • Michels-van Amelsfort JM, Walter GJ, Taams LS. CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev. Clin. Immunol. 7(4), 499–514 (2011).
  • Sugimoto H, LeBleu VS, Bosukonda D et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat. Med. 18(3), 396–404 (2012).
  • Wei L, Liu B, Tuo J et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep. 2(5), 1151–1158 (2012).
  • den Hollander AI, Koenekoop RK, Yzer S et al. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am. J. Hum. Genet. 79(3), 556–561 (2006).
  • Hayday AC, Peakman M. The habitual, diverse and surmountable obstacles to human immunology research. Nat. Immunol. 9(6), 575–580 (2008).
  • Veldhoen M, Hirota K, Westendorf AM et al. The aryl hydrocarbon receptor links Th17-cell-mediated autoimmunity to environmental toxins. Nature 453(7191), 106–109 (2008).
  • Li Y, Innocentin S, Withers DR et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147(3), 629–640 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.